Asaduzzaman, Muhammad <br/><br/>
Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.  [electronic resource] 

 -  Breast cancer research and treatment  Jun 2017 
 - 461-474 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-017-4202-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 2--genetics<br/>Breast Neoplasms--drug therapy<br/>Calpain--genetics<br/>Carcinoembryonic Antigen--genetics<br/>Cell Plasticity--genetics<br/>Cell Proliferation--genetics<br/>Drug Resistance, Neoplasm--genetics<br/>E1A-Associated p300 Protein--genetics<br/>Female<br/>GPI-Linked Proteins--genetics<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Lentivirus--genetics<br/>MCF-7 Cells<br/>Neoplasm Metastasis<br/>Neoplasm Proteins--genetics<br/>Neoplastic Stem Cells--metabolism<br/>Paclitaxel--administration & dosage<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>Transforming Growth Factor beta2--genetics